Prudent Man Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.73M Buy
2,966
+1,183
+66% +$1.2M 0.82% 31
2025
Q4
$1.92M Buy
1,783
+906
+103% +$866K 0.7% 27
2025
Q3
$669K Sell
877
-108
-11% -$80.4K 0.25% 81
2025
Q2
$768K Buy
985
+217
+28% +$169K 0.24% 95
2025
Q1
$634K Buy
768
+91
+13% +$75.7K 0.23% 102
2024
Q4
$523K Buy
677
+365
+117% +$302K 0.19% 114
2024
Q3
$276K Buy
+312
New +$281K 0.09% 140

Other funds holding LLY

Prudent Man Advisors's LLY Position: Q1 2026 in Review

Prudent Man Advisors increased its Eli Lilly (LLY) stake by 66% in Q1 2026, buying an estimated $1.2M and bringing the position to 2,966 shares worth $2.73M. The position accounts for 0.82% of the portfolio, ranked #31.

Prudent Man Advisors first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Prudent Man Advisors held 2,966 shares of Eli Lilly worth $2.73M as of Q1 2026.
  • Prudent Man Advisors bought 1,183 Eli Lilly shares in Q1 2026, an estimated $1.2M.
  • Eli Lilly made up 0.82% of Prudent Man Advisors's portfolio in Q1 2026, its #31 holding.
  • Prudent Man Advisors first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Prudent Man Advisors's 13F filing for Q1 2026, filed 8 May 2026.